Compounds > sulforaphane
Page last updated: 2024-08-16

sulforaphane and cyclin d1

sulforaphane has been researched along with cyclin d1 in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's4 (44.44)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Ahmed, T; Chiao, JW; Chung, FL; Conaway, CC; Kancherla, R; Mittelman, A1
Chen, C; Gélinas, C; Kong, AN; Shen, G; Xu, C1
Chen, C; Hebbar, V; Kong, AN; Shen, G; Xu, C1
Gackowska, L; Gagat, M; Grzanka, D; Klimaszewska-Wiśniewska, A; Krajewski, A; Litwiniec, A; Safiejko-Mroczka, B; Żuryń, A1
Han, Z; Li, C; Xu, Q; Zhao, H1
Segar, L; Shawky, NM1
Grzanka, A; Grzanka, D; Klimaszewska-Wiśniewska, A; Krajewski, A; Żuryń, A1
Anderson, J; Do, LAH; Higgins, RA; Karagiannis, TC; Licciardi, PV; Luwor, RB; Mazarakis, N; Snibson, KJ; Toh, ZQ1
Al-Gayyar, MMH; Alattar, A; Alshaman, R1

Other Studies

9 other study(ies) available for sulforaphane and cyclin d1

ArticleYear
Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells.
    International journal of oncology, 2002, Volume: 20, Issue:3

    Topics: Anticarcinogenic Agents; Apoptosis; Cell Cycle; Cell Division; Cyclin D1; Dose-Response Relationship, Drug; Humans; Isothiocyanates; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Sulfoxides; Thiocyanates; Tumor Cells, Cultured

2002
Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
    Oncogene, 2005, Jun-30, Volume: 24, Issue:28

    Topics: Anticarcinogenic Agents; bcl-X Protein; Cell Line, Tumor; Cell Survival; Cyclin D1; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; I-kappa B Proteins; Isothiocyanates; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Sulfoxides; Thiocyanates; Transcription, Genetic; Vascular Endothelial Growth Factor A

2005
p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1.
    Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:3

    Topics: Acetylcysteine; Anticarcinogenic Agents; Blotting, Western; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme Activation; G1 Phase; Gene Expression; Glutathione; HT29 Cells; Humans; Isothiocyanates; Mitogen-Activated Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; Sulfoxides; Tetrazolium Salts; Thiocyanates; Time Factors; Tumor Suppressor Protein p53; Up-Regulation

2006
The effect of sulforaphane on the cell cycle, apoptosis and expression of cyclin D1 and p21 in the A549 non-small cell lung cancer cell line.
    International journal of oncology, 2016, Volume: 48, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Lung Neoplasms; Sulfoxides

2016
Effects of sulforaphane on neural stem cell proliferation and differentiation.
    Genesis (New York, N.Y. : 2000), 2017, Volume: 55, Issue:3

    Topics: Animals; Anticarcinogenic Agents; beta Catenin; Cell Proliferation; Cells, Cultured; Cyclin D1; Isothiocyanates; Neural Stem Cells; Neurogenesis; Rats; Rats, Sprague-Dawley; Sulfoxides; Wnt Signaling Pathway

2017
Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.
    Pharmacological research, 2017, Volume: 119

    Topics: Animals; Antioxidants; Cell Line; Cell Proliferation; Cyclin D1; Humans; Isothiocyanates; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; NF-E2-Related Factor 2; Platelet-Derived Growth Factor; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sulfoxides; TOR Serine-Threonine Kinases

2017
Expression of cyclin B1, D1 and K in non‑small cell lung cancer H1299 cells following treatment with sulforaphane.
    Oncology reports, 2019, Volume: 41, Issue:2

    Topics: Anticarcinogenic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Division; Cell Line, Tumor; Cyclin B1; Cyclin D1; Cyclins; Humans; Isothiocyanates; Lung Neoplasms; Sulfoxides

2019
The effects of the dietary compound L-sulforaphane against respiratory pathogens.
    International journal of antimicrobial agents, 2021, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Cell Line; Cyclin D1; Haemophilus Infections; Haemophilus influenzae; Heme Oxygenase-1; HL-60 Cells; Humans; Isothiocyanates; Macrophages; Microbial Sensitivity Tests; NF-E2-Related Factor 2; Opsonization; Pneumococcal Infections; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Sulfoxides; THP-1 Cells; Vegetables

2021
Therapeutic effects of sulforaphane in ulcerative colitis: effect on antioxidant activity, mitochondrial biogenesis and DNA polymerization.
    Redox report : communications in free radical research, 2022, Volume: 27, Issue:1

    Topics: Animals; Antioxidants; Colitis, Ulcerative; Cyclin D1; DNA; Isothiocyanates; Mammals; NF-E2-Related Factor 2; Organelle Biogenesis; Polymerization; Proliferating Cell Nuclear Antigen; Rats; Sulfoxides; TOR Serine-Threonine Kinases

2022